Works matching IS 08876924 AND DT 2006 AND VI 20 AND IP 6

Results: 49

Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations.

Published in:

Leukemia (08876924), 2006, v. 20, n. 6, p. 1103, doi. 10.1038/sj.leu.2404149

By:

Gorello, P.;
Cazzaniga, G.;
Alberti, F.;
Dell'Oro, M. G.;
Gottardi, E.;
Specchia, G.;
Roti, G.;
Rosati, R.;
Martelli, M. F.;
Diverio, D.;
Coco, F. Lo;
Biondi, A.;
Saglio, G.;
Mecucci, C.;
Falini, B.

Publication type:

Article

Characterization of a recurrent translocation t(2;3)(p15–22;q26) occurring in acute myeloid leukemia.

Published in:

2006

By:

Trubia, M.;
Albano, F.;
Cavazzini, F.;
Cambrin, G. R.;
Quarta, G.;
Fabbiano, F.;
Ciambelli, F.;
Magro, D.;
Hernandez, J. M.;
Mancini, M.;
Diverio, D.;
Pelicci, P. G.;
Coco, F. L.;
Mecucci, C.;
Specchia, G.;
Rocchi, M.;
Liso, V.;
Castoldi, G.;
Cuneo, A.

Publication type:

Correction Notice

Molecular persistence of chronic myeloid leukemia caused by donor T cells specific for lineage-restricted maturation antigens not recognizing immature progenitor-cells.

Published in:

Leukemia (08876924), 2006, v. 20, n. 6, p. 1040, doi. 10.1038/sj.leu.2404169

By:

von dem Borne, P. A.;
van Luxemburg-Heijs, S. A. P.;
Heemskerk, M. H. M.;
Jedema, I.;
Mulder, A.;
Willemze, R.;
Falkenburg, J. H. F.

Publication type:

Article

Comparison between anagrelide and hydroxycarbamide in their activities against haematopoietic progenitor cell growth and differentiation: selectivity of anagrelide for the megakaryocytic lineage.

Published in:

2006

By:

Hong, Y.;
Wang, G.;
del Arroyo, A. Gutierrez;
Hernandez, J.;
Skene, C.;
Erusalimsky, J. D.

Publication type:

journal article

Paucity of FOXP3<sup>+</sup> cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.

Published in:

Leukemia (08876924), 2006, v. 20, n. 6, p. 1123, doi. 10.1038/sj.leu.2404182

By:

Klemke, C.-D.;
Fritzsching, B.;
Franz, B.;
Kleinmann, E. V.;
Oberle, N.;
Poenitz, N.;
Sykora, J.;
Banham, A. H.;
Roncador, G.;
Kuhn, A.;
Goerdt, S.;
Krammer, P. H.;
Suri-Payer, E.

Publication type:

Article

Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation.

Published in:

2006

By:

Reiniger, L.;
Bödör, C.;
Bognár, Á;
Balogh, Z.;
Csomor, J.;
Szepesi, Á;
Kopper, L.;
Matolcsy, A.;
Bödör, C;
Bognár, A;
Szepesi, A

Publication type:

journal article

Clone wars in CML.

Published in:

Leukemia (08876924), 2006, v. 20, n. 6, p. 939, doi. 10.1038/sj.leu.2404184

By:

Giles, F. J.

Publication type:

Article

Redirection of CMV-specific CTL towards B-CLL via CD20-targeted HLA/CMV complexes.

Published in:

Leukemia (08876924), 2006, v. 20, n. 6, p. 1096, doi. 10.1038/sj.leu.2404185

By:

Mous, R.;
Savage, P.;
Remmerswaal, E. B. M.;
van Lier, R. A. W.;
Eldering, E.;
van Oers, M. H. J.

Publication type:

Article

Mutations of N-RAS, FLT3 and p53 genes are not involved in the development of acute leukemia transformed from myeloproliferative diseases with JAK2 mutation.

Published in:

2006

By:

Suzuki, M.;
Abe, A.;
Kiyoi, H.;
Murata, M.;
Ito, Y.;
Shimada, K.;
Morishita, Y.;
Kinoshita, T.;
Naoe, T.

Publication type:

Letter

HOXA cluster deregulation in T-ALL associated with both a TCRD-HOXA and a CALM-AF10 chromosomal translocation.

Published in:

2006

By:

Bergeron, J.;
Clappier, E.;
Cauwelier, B.;
Dastugue, N.;
Millien, C.;
Delabesse, E.;
Beldjord, K.;
Speleman, F.;
Soulier, J.;
Macintyre, E.;
Asnafi, V.

Publication type:

Letter

Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML).

Published in:

Leukemia (08876924), 2006, v. 20, n. 6, p. 965, doi. 10.1038/sj.leu.2404188

By:

Boissel, N.;
Leroy, H.;
Brethon, B.;
Philippe, N.;
de Botton, S.;
Auvrignon, A.;
Raffoux, E.;
Leblanc, T.;
Thomas, X.;
Hermine, O.;
Quesnel, B.;
Baruchel, A.;
Leverger, G.;
Dombret, H.;
Preudhomme, C.

Publication type:

Article

BCR-ABL activity and its response to drugs can be determined in CD34+ CML stem cells by CrkL phosphorylation status using flow cytometry.

Published in:

2006

By:

Hamilton, A.;
Elrick, L.;
Myssina, S.;
Copland, M.;
Jørgensen, H.;
Melo, J. V.;
Holyoake, T.;
Jørgensen, H

Publication type:

journal article

Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndrome.

Published in:

2006

By:

Chen, C.-Y.;
Lin, L.-I.;
Tang, J.-L.;
Tsay, W.;
Chang, H.-H.;
Yeh, Y.-C.;
Huang, C.-F.;
Chiou, R.-J.;
Yao, M.;
Ko, B.-S.;
Chen, Y.-C.;
Lin, K.-H.;
Lin, D.-T.;
Tien, H.-F.

Publication type:

Letter

Reliability of quantitative chimerism results: assessment of sample performance using novel parameters.

Published in:

2006

By:

Kristt, D.;
Klein, T.

Publication type:

Letter

Molecular pathogenesis of MALT lymphoma: two signaling pathways underlying the antiapoptotic effect of API2-MALT1 fusion protein.

Published in:

Leukemia (08876924), 2006, v. 20, n. 6, p. 929, doi. 10.1038/sj.leu.2404192

By:

Nakagawa, M.;
Seto, M.;
Hosokawa, Y.

Publication type:

Article

Epigenetic disruption of two proapoptotic genes MAPK10/JNK3 and PTPN13/FAP-1 in multiple lymphomas and carcinomas through hypermethylation of a common bidirectional promoter.

Published in:

2006

By:

Ying, J.;
Li, H.;
Cui, Y.;
Wong, A. H. Y.;
Langford, C.;
Tao, Q.

Publication type:

Letter

t(5;12)(q23–31;p13) with ETV6-ACSL6 gene fusion in polycythemia vera.

Published in:

2006

By:

Murati, A.;
Adélaïde, J.;
Gelsi-Boyer, V.;
Etienne, A.;
Rémy, V.;
Fezoui, H.;
Sainty2,3, D.;
Xerri, L.;
Vey, N.;
Olschwang, S.;
Birnbaum, D.;
Chaffanet, M.;
Mozziconacci, M. J.

Publication type:

Letter

Inactivation of p53 and deletion of ATM in B-CLL patients in relation to IgVH mutation status and previous treatment.

Published in:

2006

By:

Trbusek, M.;
Malcikova, J.;
Smardova, J.;
Kuhrova, V.;
Mentzlova, D.;
Francova, H.;
Bukovska, S.;
Svitakova, M.;
Kuglik, P.;
Linkova, V.;
Doubek, M.;
Brychtova, Y.;
Zacal, J.;
Kujickova, J.;
Pospisilova, S.;
Dvorakova, D.;
Vorlicek, J.;
Mayer, J.

Publication type:

Letter

The lack of association between JAK2 V617F mutation and myelodysplastic syndrome with or without myelofibrosis.

Published in:

2006

By:

Yip, S.-F.;
So, C.-C.;
Chan, Ay.-Y.;
Liu, Hs.-Y.;
Wan, Ts.-K.;
Chan, L.-C.

Publication type:

Letter

Identification of genes involved in imatinib resistance in CML: a gene-expression profiling approach.

Published in:

Leukemia (08876924), 2006, v. 20, n. 6, p. 1047, doi. 10.1038/sj.leu.2404197

By:

Villuendas, R.;
Steegmann, J. L.;
Pollán, M.;
Tracey, L.;
Granda, A.;
Fernández-Ruiz, E.;
Casado, L. F.;
Martínez, J.;
Martínez, P.;
Lombardía, L.;
Villalón, L.;
Odriozola, J.;
Piris, M. A.

Publication type:

Article

Upregulation of Bfl-1/A1 in leukemia cells undergoing differentiation by all-trans retinoic acid treatment attenuates chemotherapeutic agent-induced apoptosis.

Published in:

2006

By:

Xia, L.;
Wurmbach, E.;
Waxman, S.;
Jing, Y.

Publication type:

journal article

Autoimmune hemolytic anemias and IgG antierythrocyte autoantibodies in Waldenström's macroglobulinemia: association with FcγRIIa polymorphism.

Published in:

2006

By:

Poulain, S.;
Dervite, I.;
Leleu, X.;
Fernandes, J.;
Stalnikiewicz, L.;
Moreau, A.-S.;
Coiteux, V.;
de Botton, S.;
Duthilleul, P.;
Morel, P.

Publication type:

Letter

Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo.

Published in:

2006

By:

Navas, T. A.;
Nguyen, A. N.;
Hideshima, T.;
Reddy, M.;
Ma, J. Y.;
Haghnazari, E.;
Henson, M.;
Stebbins, E. G.;
Kerr, I.;
O'Young, G.;
Kapoun, A. M.;
Chakravarty, S.;
Mavunkel, B.;
Perumattam, J.;
Luedtke, G.;
Dugar, S.;
Medicherla, S.;
Protter, A. A.;
Schreiner, G. F.;
Anderson, K. C.

Publication type:

journal article

HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations.

Published in:

Leukemia (08876924), 2006, v. 20, n. 6, p. 1145, doi. 10.1038/sj.leu.2404201

By:

De Re, V.;
Sansonno, D.;
Simula, M. P.;
Caggiari, L.;
Gasparotto, D.;
Fabris, M.;
Tucci, F. A.;
Racanelli, V.;
Talamini, R.;
Campagnolo, M.;
Geremia, S.;
Dammacco, F.;
De Vita, S.

Publication type:

Article

The fibroblast growth factors in multiple myeloma.

Published in:

2006

By:

Krejci, P.;
Mekikian, P. B.;
Wilcox, W. R.

Publication type:

Letter

Activation of FGFR1β signaling pathway promotes survival, migration and resistance to chemotherapy in acute myeloid leukemia cells.

Published in:

Leukemia (08876924), 2006, v. 20, n. 6, p. 979, doi. 10.1038/sj.leu.2404203

By:

Karajannis, M. A.;
Vincent, L.;
DiRenzo, R.;
Shmelkov, S. V.;
Zhang, F.;
Feldman, E. J.;
Bohlen, P.;
Zhu, Z.;
Sun, H.;
Kussie, P.;
Rafii, S.

Publication type:

Article

The role of the nuclear Akt activation and Akt inhibitors in all-trans-retinoic acid-differentiated HL-60 cells.

Published in:

2006

By:

Matkovic, K.;
Brugnoli, F.;
Bertagnolo, V.;
Banfic, H.;
Visnjic, D.

Publication type:

journal article

Aberrant gene promoter methylation marking disease progression in multiple myeloma.

Published in:

2006

By:

Chim, C.-S.;
Liang, R.;
Leung, M.-H.;
Yip, S.-F.;
Kwong, Y.-L.

Publication type:

Letter

JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained.

Published in:

2006

By:

Steensma, D. P.;
McClure, R. F.;
Karp, J. E.;
Tefferi, A.;
Lasho, T. L.;
Powell, H. L.;
DeWald, G. W.;
Kaufmann, S. H.

Publication type:

journal article

Twenty-seven cases of drug-induced interstitial lung disease associated with imatinib mesylate.

Published in:

2006

By:

Ohnishi, K.;
Sakai, F.;
Kudoh, S.;
Ohno, R.

Publication type:

Letter

Genomic gain at 6p21: a new cryptic molecular rearrangement in secondary myelodysplastic syndrome and acute myeloid leukemia.

Published in:

Leukemia (08876924), 2006, v. 20, n. 6, p. 958, doi. 10.1038/sj.leu.2404208

By:

La Starza, R.;
Aventin, A.;
Matteucci, C.;
Crescenzi, B.;
Romoli, S.;
Testoni, N.;
Pierini, V.;
Ciolli, S.;
Sambani, C.;
Locasciulli, A.;
Di Bona, E.;
Lafage-Pochitaloff, M.;
Martelli, M. F.;
Marynen, P.;
Mecucci, C.

Publication type:

Article

A quantitative assay for JAK2<sup>V617F</sup> mutation in myeloproliferative disorders by ARMS-PCR and capillary electrophoresis.

Published in:

Leukemia (08876924), 2006, v. 20, n. 6, p. 1055, doi. 10.1038/sj.leu.2404209

By:

Vannucchi, A. M.;
Pancrazzi, A.;
Bogani, C.;
Antonioli, E.;
Guglielmelli, P.

Publication type:

Article

Identification of truncated RUNX1 and RUNX1-PRDM16 fusion transcripts in a case of t(1;21)(p36;q22)-positive therapy-related AML.

Published in:

2006

By:

Stevens-Kroef, M.-J. P. L.;
Schoenmakers, E. F. P. M.;
van Kraaij, M.;
Huys, E.;
Vermeulen, S.;
van der Reijden, B.;
van Kessel, A. Geurts

Publication type:

Letter

MLL rearrangements emerge during spontaneous apoptosis of clinical blood samples.

Published in:

2006

By:

Basecke, J.;
Karim, K.;
Podleschny, M.;
Becker, A.;
Glass, B.;
Trumper, L.;
Griesinger, F.

Publication type:

Letter

Identification and characterization of a novel zinc finger protein (HZF1) gene and its function in erythroid and megakaryocytic differentiation of K562 cells.

Published in:

Leukemia (08876924), 2006, v. 20, n. 6, p. 1109, doi. 10.1038/sj.leu.2404212

By:

Peng, H.;
Du, Z.-W.;
Zhang, J.-W.

Publication type:

Article

Phase 1 study of PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor, for the treatment of acute myeloid leukemia and myelodysplastic syndrome.

Published in:

Leukemia (08876924), 2006, v. 20, n. 6, p. 952, doi. 10.1038/sj.leu.2404213

By:

Roboz, G. J.;
Giles, F. J.;
List, A. F.;
Cortes, J. E.;
Carlin, R.;
Kowalski, M.;
Bilic, S.;
Masson, E.;
Rosamilia, M.;
Schuster, M. W.;
Laurent, D.;
Feldman, E. J.

Publication type:

Article

Essential thrombocythemias without V617F JAK2 mutation are clonal hematopoietic stem cell disorders.

Published in:

2006

By:

Kiladjian, J.-J.;
Elkassar, N.;
Cassinat, B.;
Hetet, G.;
Giraudier, S.;
Balitrand, N.;
Conejero, C.;
Briere, J.;
Fenaux, P.;
Chomienne, C.;
Grandchamp, B.

Publication type:

Letter

Inducible expression of AML1-ETO fusion protein endows leukemic cells with susceptibility to extrinsic and intrinsic apoptosis.

Published in:

Leukemia (08876924), 2006, v. 20, n. 6, p. 987, doi. 10.1038/sj.leu.2404218

By:

Lu, Y.;
Xu, Y.-B.;
Yuan, T.-T.;
Song, M.-G.;
Lübbert, M.;
Fliegauf, M.;
Chen, G.-Q.

Publication type:

Article

Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression.

Published in:

2006

By:

Bilban, M.;
Heintel, D.;
Scharl, T.;
Woelfel, T.;
Auer, M. M.;
Porpaczy, E.;
Kainz, B.;
Kröber, A.;
Carey, V. J.;
Shehata, M.;
Zielinski, C.;
Pickl, W.;
Stilgenbauer, S.;
Gaiger, A.;
Wagner, O.;
Jäger, U.;
Kröber, A;
Jäger, U;
German CLL Study Group

Publication type:

journal article

Physical association of the patient-specific GATA1 mutants with RUNX1 in acute megakaryoblastic leukemia accompanying Down syndrome.

Published in:

Leukemia (08876924), 2006, v. 20, n. 6, p. 1002, doi. 10.1038/sj.leu.2404223

By:

Xu, G.;
Kanezaki, R.;
Toki, T.;
Watanabe, S.;
Takahashi, Y.;
Terui, K.;
Kitabayashi, I.;
Ito, E.

Publication type:

Article

Toll-like receptors mediate proliferation and survival of multiple myeloma cells.

Published in:

2006

By:

Bohnhorst, J.;
Rasmussen, T.;
Moen, S. H.;
Fløttum, M.;
Knudsen, L.;
Børset, M.;
Espevik, T.;
Sundan, A.;
Fløttum, M;
Børset, M

Publication type:

journal article

Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors.

Published in:

Leukemia (08876924), 2006, v. 20, n. 6, p. 1130, doi. 10.1038/sj.leu.2404226

By:

Jego, G.;
Bataille, R.;
Geffroy-Luseau, A.;
Descamps, G.;
Pellat-Deceunynck, C.

Publication type:

Article

Gene expression profiling of CD34+ cells identifies a molecular signature of chronic myeloid leukemia blast crisis.

Published in:

Leukemia (08876924), 2006, v. 20, n. 6, p. 1028, doi. 10.1038/sj.leu.2404227

By:

Zheng, C.;
Li, L.;
Haak, M.;
Brors, B.;
Frank, O.;
Giehl, M.;
Fabarius, A.;
Schatz, M.;
Weisser, A.;
Lorentz, C.;
Gretz, N.;
Hehlmann, R.;
Hochhaus, A.;
Seifarth, W.

Publication type:

Article

Inflammation and multiple myeloma: the Toll connection.

Published in:

Leukemia (08876924), 2006, v. 20, n. 6, p. 937, doi. 10.1038/sj.leu.2404229

By:

Mantovani, A.;
Garlanda, C.

Publication type:

Article

The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro.

Published in:

Leukemia (08876924), 2006, v. 20, n. 6, p. 1073, doi. 10.1038/sj.leu.2404230

By:

Steele, A. J.;
Jones, D. T.;
Ganeshaguru, K.;
Duke, V. M.;
Yogashangary, B. C.;
North, J. M.;
Lowdell, M. W.;
Kottaridis, P. D.;
Mehta, A. B.;
Prentice, A. G.;
Hoffbrand, A. V.;
Wickremasinghe, R. G.

Publication type:

Article

A novel MHC-associated Proteinase 3 peptide isolated from primary chronic myeloid leukaemia cells further supports the significance of this antigen for the immunotherapy of myeloid leukaemias.

Published in:

Leukemia (08876924), 2006, v. 20, n. 6, p. 1067, doi. 10.1038/sj.leu.2404234

By:

Knights, A. J.;
Weinzierl, A. O.;
Flad, T.;
Guinn, B.-a.;
Mueller, L.;
Mufti, G. J.;
Stevanovic, S.;
Pawelec, G.

Publication type:

Article

Molecular profiling reveals myeloid leukemia cell lines to be faithful model systems characterized by distinct genomic aberrations.

Published in:

Leukemia (08876924), 2006, v. 20, n. 6, p. 994, doi. 10.1038/sj.leu.2404235

By:

Rücker, F. G.;
Sander, S.;
Döhner, K.;
Döhner, H.;
Pollack, J. R.;
Bullinger, L.

Publication type:

Article

Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi(ϕ)-LMC GROUP).

Published in:

Leukemia (08876924), 2006, v. 20, n. 6, p. 1061, doi. 10.1038/sj.leu.2404236

By:

Nicolini, F. E.;
Corm, S.;
Lê, Q.-H.;
Sorel, N.;
Hayette, S.;
Bories, D.;
Leguay, T.;
Roy, L.;
Giraudier, S.;
Tulliez, M.;
Facon, T.;
Mahon, F.-X.;
Cayuela, J.-M.;
Rousselot, P.;
Michallet, M.;
Preudhomme, C.;
Guilhot, F.;
Roche-Lestienne, C.

Publication type:

Article

Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.

Published in:

Leukemia (08876924), 2006, v. 20, n. 6, p. 911, doi. 10.1038/sj.leu.2404245

By:

Martelli, A. M.;
Nyåkern, M.;
Tabellini, G.;
Bortul, R.;
Tazzari, P. L.;
Evangelisti, C.;
Cocco, L.

Publication type:

Article